Erin Foster is a Dermatology physician affiliated with Oregon Health & Science University. OpenAlex indexes 33 publications with 333 citations (h-index 8); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3303 S Bond Ave
Portland, OR 972394501
Telephone
503-418-3376Provider last certified this registry record 27 May 2020.
Clinical trials
- Multicontext Approach for Cognitive Function in Parkinson Disease
Sponsor: Washington University School of Medicine
Overall officialRecruitingNCT07190404 - Everyday Memory Impairment in PD-related Cognitive Decline
Sponsor: Washington University School of Medicine
Overall officialActive, not recruitingNCT04474379 - Feasibility and Optimization of a Cognitive Intervention for Parkinson Disease
Sponsor: Washington University School of Medicine
Overall officialCompletedNCT02826785
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Arcutis Biotherapeutics, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
26.3%Corticosteroid26.3%Dexamethasone50%Clobetasol Propionate32%Betamethasone Dipropionate10%Hydrocortisone8%Part D≥52 patientsDermatology
16.7%Corticosteroid7.1%Triamcinolone Acetonide100%Part D≥49 patientsAzole Antifungal2.9%Clotrimazole100%Part D<11 patients+ 4 more classes in this area
Anti-infectives
14.4%Azole Antifungal6.5%Ketoconazole70%Fluconazole30%Part D<11 patientsTetracycline-class Drug5.6%Doxycycline Hyclate76%Doxycycline Monohydrate24%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Brian Druker, MD
Oregon Health & Science University
Kevin Winthrop, MD
Oregon Health & Science University
Richard Maziarz, MD
Oregon Health & Science University
Wayne Clark, MD
Oregon Health & Science University
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”